saikosaponin d has been researched along with Lung Injury, Acute in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Cui, N; Hu, B; Kuang, H; Peng, D; Qi, Y; Sun, Y; Wang, Q; Yang, B; Zeng, Y; Zhang, W; Zhang, Z | 1 |
| Lu, G; Song, L; Tao, Y | 1 |
| Du, ZA; Hu, ZS; Sun, MN | 1 |
3 other study(ies) available for saikosaponin d and Lung Injury, Acute
| Article | Year |
|---|---|
Saikosaponin A and Its Epimers Alleviate LPS-Induced Acute Lung Injury in Mice.
Topics: Acetic Acid; Acute Lung Injury; Animals; Anti-Inflammatory Agents; Interleukin-6; Lipopolysaccharides; Mice; NF-kappa B; Oleanolic Acid; Saponins; Tumor Necrosis Factor-alpha | 2023 |
Saikosaponin D attenuates inflammatory response and cell apoptosis of lipopolysaccharide-induced lung epithelial cells.
Topics: Acute Lung Injury; Animals; Apoptosis; Epithelial Cells; Humans; Inflammation; Lipopolysaccharides; Lung; Mice; Saponins; Sepsis | 2023 |
Saikosaponin a Ameliorates LPS-Induced Acute Lung Injury in Mice.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Caspase 1; Disease Models, Animal; Dose-Response Relationship, Drug; Inflammation Mediators; Interleukin-1beta; Lipopolysaccharides; Lung; Male; Mice, Inbred BALB C; Neutrophil Infiltration; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Oleanolic Acid; Pulmonary Edema; Saponins; Tumor Necrosis Factor-alpha | 2018 |